Reassessing Frontal Fibrosing Alopecia

    October 2008 in “ Expert Review of Dermatology
    Dimitrios Rigopoulos, Efstathios Rallis, Stamatis Gregoriou, Andreas Katsambas
    Image of study
    TLDR Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.
    The 2008 review on Frontal Fibrosing Alopecia (FFA) described it as a scarring alopecia that progresses slowly, mainly affecting the frontoparietal hairline and eyebrows, predominantly in women over 60. With only 117 cases reported, the condition was believed to be underdiagnosed. Histologically, FFA was similar to Lichen Planopilaris (LPP) and required clinicopathologic correlation for diagnosis. Treatments like oral prednisone or chloroquine were ineffective, and symptoms often worsened after stopping them. The review emphasized the need for more extensive research to understand FFA's characteristics, causes, and treatment, and questioned whether FFA should be considered a separate condition or a variant of LPP due to its unique presentation in postmenopausal women and poor response to treatment.
    Discuss this study in the Community →

    Research cited in this study

    13 / 13 results

    Related Community Posts Join

    6 / 674 results

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 2 years ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

      community scarring alopecia awareness in this community

      in Chat  33 upvotes 3 years ago
      Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

      community can someone help me identify these pls

      in Treatment 4 months ago
      The user is experiencing diffuse thinning and inflammation despite using 2.5mg dutasteride daily, ciclopirox, and ketoconazole shampoos. They are considering treatments like hydroxychloroquine and JAK inhibitors due to suspected scarring alopecia and have faced challenges in obtaining a scalp biopsy.

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  120 upvotes 5 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.

    Related Research

    4 / 4 results